Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | BL452 | — |
expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired drug used in a patient who received MMR (Priorix) (batch number BL452, expiry date 17-DEC-2024) for prophylaxis. On 17-FEB-2025, the patient received Priorix. On 17-FEB-2025, an unknown time after receiving Priorix, the patient experienced expired drug used (Verbatim: expired dose administered). The outcome of the expired drug used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-FEB-2025 Other HCP stated that their facility gave an expired dose of Priorix, which led to expired vaccine used. Reporter asked if this still be viable for the patient or should they get another dose. Patient had already been notified. HCP stated she cannot share the patient's information.